Your browser doesn't support javascript.
loading
MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy.
Petr, Vojtech; Csuka, Dorottya; Hruba, Petra; Szilágyi, Ágnes; Kollar, Marek; Slavcev, Antonij; Prohászka, Zoltán; Viklicky, Ondrej.
Affiliation
  • Petr V; Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Csuka D; First Faculty of Medicine, Charles University, Prague, Czechia.
  • Hruba P; Research Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Szilágyi Á; Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Kollar M; Research Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Slavcev A; Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Prohászka Z; Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czechia.
  • Viklicky O; Research Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Front Immunol ; 13: 985766, 2022.
Article in En | MEDLINE | ID: mdl-36189289
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Thrombotic Microangiopathies Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Thrombotic Microangiopathies Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article